$CURR News: CURE Pharmaceutical and Milagro Pharmaceuticals

New Post Public Reply Private Reply Replies (1) Message Board
trooperstocks
246
$CURR News: CURE Pharmaceutical and Milagro Pharmaceuticals Collaborate for Registration and Approval to Sell Sildenafil Oral Thin Film in Mexico

11:18 am ET March 3, 2022 (Globe Newswire)
Cure Pharmaceutical (OTC: CURR) a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, and Milagro Pharmaceuticals, which seeks first mover advantage in target heath & wellness markets through key collaborations, today announced their collaboration to register and sell in Mexico a number of CURE's OTC and medical compounds that utilize CUREform(TM), CURE's patented drug delivery platform for oral thin film (OTF). Cure is in discussions with several large distributors in Mexico and Latin America.

OTF products that will be marketed and sold in Mexico via key distribution partners, include:

-- CUREfilm Blue(TM) - an oral soluble form of sildenafil citrate (the active ingredient present in Viagra) for the treatment of erectile dysfunction (ED).

-- Vitamin D3 - that provides a convenient, weekly 40,000 IU dose of Vitamin D

-- An electrolyte energy boost - that provides a healthier, sugar-free alternative to energy drinks

-- Sleep - a dose of melatonin that dissolves on the tongue so it can be taken even after you climb into bed.

The opportunity to serve the Latin American market with this venture into Mexico is an exciting one that is expected to accelerate the ramp up of CURE's FDA-registered, cGMP manufacturing facility, where the Company pioneered and developed its patented CUREfilm(TM), drug delivery platform. The Company expects to select a distribution partner for the the LATAM territory in the coming months.

Martin Simon, CEO of Milagro Pharmaceuticals, stated, "We are pleased to be working with CURE to bring their innovative wellness products and proprietary drug forms and delivery systems to Mexico, with the intention to extend our collaboration to encompass the rest of Latin America where the demand for health & wellness products is growing more rapidly than many other parts of the world."

About CURE Pharmaceutical

CURE is the pioneering developer of CUREform(TM), a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.

As a vertically integrated company, CURE's 25,000 square foot, FDA and DEA registered, NSF cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production.

About Milagro Pharmaceuticals

Milagro Pharmaceuticals is dedicated to the innovation, distribution, and sale of various disruptive technologies all focused on healing people. The company's growth has driven its recent expansion into Colombia, Canada and now Mexico.

About COFEPRIS

COFEPRIS (the Federal Commission for Protection against Sanitary Risk (Comision Federal para la Proteccion contra Riesgos Sanitarios) is the Mexican authority responsible for enforcing the regulatory framework relating to medical products and is part of the Ministry of Health (Secretaria de Salud).

Forward Looking Statement

Statements CURE makes in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act", and Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act", which are usually identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "seeks," "should," "will," and variations of such words or similar expressions. CURE intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and is making this statement for purposes of complying with those safe harbor provisions. The forward-looking statements in this press release reflect CURE's judgment as of the date of this press release. CURE disclaims any intent or obligation to update these forward-looking statements.

Viagra is a registered trademark of Pfizer Inc.

Investor Contact:

Mike Redard

investor@curepharma.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 156

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading
ETCO Targets the Unflashy Weak Link in Battery Storage

Updated Category News Views 0

A battery cabinet can look impressive right up until one lousy connection becomes the problem nobody budgeted for. ETCO Incorporated’s new lineup of standard and custom connectors and terminals goes after that unglamorous part of battery energy storage systems: the physical handoff points carrying power, grounding equipment, and tying auxiliary components together. It...

Continue Reading
Scalefusion’s Platinum Win Sharpens Its Brand Story

Updated Category News Views 46

A Film Is Not a Balance Sheet A slick brand film cannot patch a leaky product, but it can make a complicated platform easier to remember. That is the sensible takeaway from Scalefusion’s Platinum Level win at the 2026 MarCom Awards for “One Platform. One Agent. We are Scalefusion.” The recognition is for creative execution, not commercial performance, and anybody...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 118

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 39

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 105

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 143

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 51

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 310

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 153

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading

Top 5 Most Recently Viewed Articles

Gerald Group Achieves Milestone Financing with New Facility

Updated Category News Views 187

Gerald Group Secures Significant Financing with New Credit Structure Gerald Group, a prominent player in the global trading domain focused on metals and minerals, has achieved a remarkable milestone with the recent refinancing of its Revolving Credit Facility (RCF). This year marks the sixteenth annual iteration of this financial strategy, culminating in an impressive sum...

Continue Reading
eXp World Holdings Reports Strong Q2 Growth and Expansion Plans

Updated Category News Views 143

eXp World Holdings Reports Strong Q2 Growth In its recent earnings call, eXp World Holdings (NASDAQ: EXPI) highlighted its impressive financial results and strategic initiatives aimed at global expansion and improving agent productivity. The company achieved a significant 5% revenue growth, totaling $1.295 billion for Q2 2024, along with a noteworthy 6% rise in agent...

Continue Reading
GigaWatt's Innovative Approach to Crowdfunding Solar Investments

Updated Category News Views 183

GigaWatt's Innovative Growth Strategy in Solar Energy GigaWatt Inc. is embarking on an exciting opportunity for public investment as the demand for residential solar energy rises. The need for energy independence is escalating, with homeowners seeking alternatives as grid pressures and electricity costs continue to rise. With a focus on user-friendly solutions, GigaWatt...

Continue Reading
CIC Services Takes Bold Stand Against IRS Overreach on Captives

Updated Category News Views 186

CIC Services Takes A Stand Against IRS Regulations CIC Services, an industry leader in captive insurance management, has embarked on a significant legal battle against the Internal Revenue Service (IRS). This lawsuit is the second of its kind, focusing on the IRS's perceived regulatory overreach, which threatens to undermine the financial stability of small and mid-sized...

Continue Reading
Itaú Unibanco Declares Interest on Capital for Shareholders

Updated Category News Views 425

Itaú Unibanco Announces Payment of Interest on Capital Itaú Unibanco Holding S.A. has made an important announcement regarding the payment of interest on capital (IOC) to its stockholders. This decision reflects the Bank's ongoing commitment to its shareholders and their returns on investment. Details of the Payment During a recent meeting, the Board of Directors...

Continue Reading